Results
|
67301.
|
|
|
67302.
|
|
|
67303.
|
|
|
67304.
|
|
|
67305.
|
|
|
67306.
|
The first steps towards the era of personalised vaccinology: predicting adverse reactions. [electronic resource] by
- Pellegrino, P
- Falvella, F S
- Perrone, V
- Carnovale, C
- Brusadelli, T
- Pozzi, M
- Antoniazzi, S
- Cheli, S
- Perrotta, C
- Clementi, E
- Radice, S
Producer: 20160210
In:
The pharmacogenomics journal vol. 15
Availability: No items available.
|
|
67307.
|
|
|
67308.
|
|
|
67309.
|
|
|
67310.
|
|
|
67311.
|
|
|
67312.
|
A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia. [electronic resource] by
- Strati, Paolo
- Tong, Wei-Gang
- Vitale, Candida
- Wierda, William G
- O'Brien, Susan
- Brown, Jennifer R
- Weng, Wen-Kai
- Kipps, Thomas
- Keating, Michael J
- Ferrajoli, Alessandra
Producer: 20160412
In:
Leukemia & lymphoma vol. 56
Availability: No items available.
|
|
67313.
|
|
|
67314.
|
|
|
67315.
|
Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma. [electronic resource] by
- Lossos, Izidore S
- Fabregas, Jesus C
- Koru-Sengul, Tulay
- Miao, Feng
- Goodman, Deborah
- Serafini, Aldo N
- Hosein, Peter J
- Stefanovic, Alexandra
- Rosenblatt, Joseph D
- Hoffman, James E
Producer: 20160412
In:
Leukemia & lymphoma vol. 56
Availability: No items available.
|
|
67316.
|
|
|
67317.
|
|
|
67318.
|
|
|
67319.
|
|
|
67320.
|
|